Drugs / Myoblast transplantation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02196467 | May 2014 → Jan 2024 | Duchenne muscular dystrophy | CHU de Quebec-Universite Laval | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Myoblast transplantation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02196467 ↗ |
| Action | Restore | “restoration of the dystrophin protein in several myofibers” NCT02196467 ↗ |
| Modality | Cell therapy | “transplantation of normal myoblasts” NCT02196467 ↗ |
| Route | Intramuscular | “Following intramuscular injection” NCT02196467 ↗ |